An OCTA data set selected from the Leuven Eye Study cohort,
12 was used in this study. Thirty-nine healthy subjects (aged 63
\(\pm\) 13 years) and 82 glaucoma patients (aged 69
\(\pm\) 10 years with an average visual field mean deviation [VF MD] of –8.1
\(\pm\) 6.7 dB) were included, as shown in
Table 1. The OCTA data in the Leuven Eye Study cohort consist of, for each subject, a 3
\(\times\)3-mm optic disc centered angiography scan acquired (via undilated pupil) using the Cirrus 5000 HD OCT (Carl Zeiss, Dublin, CA, USA; 10.0 software version). In this cohort, healthy individuals were recruited from those accompanying glaucoma patients. The exclusion criteria included blood relatives, those with a family history of glaucoma, rim notching or thinning, optic disc structural changes such as asymmetrical cup/disc ratio, disc hemorrhage, or an IOP above 21 mm Hg. Patients with glaucoma were defined as having characteristic optic disc damage and visual field loss as defined elsewhere.
32 Glaucoma patients were excluded if they had a history of ocular trauma or any other eye disease (including high ametropias, defined as hyperopia higher than 4 diopters and myopia higher than 6 diopters). Additionally, patients with diabetes mellitus were excluded, since it is a known confounder in vascular-related research. Patients with open-angle glaucoma were stratified based on their maximal recorded untreated IOP as having POAG (> 21 mm Hg) or NTG if equal or below that threshold. The eye with greater glaucomatous damage was chosen to be included in the study whenever both eyes were considered eligible. Six layers (superficial and deep vascular plexus, avascular, whole retina, choriocapillaris, and choroid) segmented by the manufacturer’s software were exported (see
Fig. 2). Although the avascular layer should not contain flow information, the glaucoma progression or the performance of the device’s layer segmentation software may lead to microvasculature imaged in this layer, as seen in
Figure 2. Therefore, the avascular layer was also included in order to maximize the information retrieved from the OCTA scan. Images with signal strength index below the suggested inclusion value provided by the manufacturer, 6 out of 10,
33 were excluded from the study. Images with severe movement artifacts or visible floaters were also excluded. In addition to the angiography scans, the averaged circumpapillary RNFL thicknesses were exported from the device. The glaucoma group was further divided by severity. Patients with a VF MD higher than –6 dB were considered mild (37 subjects), between –6 and –12 dB were considered moderate (26 subjects), and those with a VF MD worse than –12 dB were considered severe (19 subjects). Visual fields were obtained using the Humphrey Field Analyzer (HFA) (Zeiss, Oberkochen, Germany) or the Octopus (Interzeag, Schlieren, Switzerland) perimeters on the same day as the OCT and OCTA examinations. The visual field programs were the 24-2 SITA standard program (HFA) or the G1 dynamic strategy (Octopus). The VF MD was extracted through a software that can extract data from both devices (Peridata; PeriData Software GmbH, Germany, version 3.5.4). Unreliable VFs (false positive
\(\gt\!\!20\%\), false negative
\(\gt\!\!40\%\), or fixation loss
\(\gt\!\!30\%\)) were excluded from analysis. These cutoffs are set by default by the manufacturer and widely used in previously published studies. The study adhered to the tenets of the Declaration of Helsinki, and it was approved by the Institutional Review Board of the University Hospitals Leuven. An informed consent was signed by all the participants prior to the study evaluation.